Sucampo Pharma (SCMP) Tops Q2 EPS by 1c

Sucampo Pharma (NASDAQ: SCMP) reported Q2 EPS of $0.23, $0.01 better than the analyst estimate of $0.22. Revenue for the quarter came in at $52 million versus the consensus estimate of $48.61 million.

For earnings history and earnings-related data on Sucampo Pharma (SCMP) click here.

You May Also Be Interested In

• SanDisk stock target lifted by Citi on continued demand strength
• Acuity Brands (AYI) Tops Q3 EPS by 15c
• BlackBerry surges on earnings beat and strong cash flow